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ess: edgonc@ono.com (Summary Question of the study: The aim of our study was to examine the
relationship between health-related quality of life (HRQL), lung function parameters
and intensity of dyspnea in order to determinate what variables influence the HRQL
in patients with pulmonary emphysema.
Patients and methods: Forty (mean aged 6679) consecutive male patients with
pulmonary emphysema were evaluated. All patients underwent spirometry,
measurement of lung volumes, inspiratory and expiratory respiratory pressure (MIP
and MEP), measurement of corrected carbon monoxide diffusing capacity (KCO), and
6-min walking test (6MWT). The scale of dyspnea by the baseline dyspnea index (BDI)
and British Medical Council Research (MCR), and the quality of life by Chronic
Respiratory Question Disease (CRQD) were also assessed.
Results: FEV1, FVC, 6MWT, KCO, MEP, MIP, BDI and MCR were correlated with
dimensions of CRQD. Factor analysis reduced these variables to four factors, which
accounted for 86.2% of the total variance: (1) airway obstruction, (2) dyspnea, (3)
capacity of effort, (4) maximum static respiratory pressure. In the multiple
regression model BDI and MEP explained the 64% of the total variance of CRQD.
Conclusions: Quality of life measured by CRQD in patients with emphysema is
predominantly determined by dyspnea, and in minor degree by expiratory muscle
strength. Our results underscore the usefulness of dyspnea scales and MEP in the
evaluation of HRQL in patients with emphysema.
& 2004 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
2 89009.
E. Gonza´lez).Introduction
Health-related quality of life (HRQL) is a central
component of study in patients with chronic
obstructive pulmonary disease (COPD). HRQL ques-
tionnaires quantify the impact of the disease anded.
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HRQL in patients with pulmonary emphysema 639treatments in a standardized manner.1 Chronic
Respiratory Question Disease (CRQD)2 and St.
George’s Respiratory Questionnaire3 are examples
of specific instruments to assess quality of life in
lung-diseases. Although a weak relationship be-
tween pulmonary function parameters and HRQL
has been reported,4–7 no single physiologic mea-
surement accurately encompass HRQL in patients
with COPD. There is little information on HRQL in
patients with pulmonary emphysema without in-
dication of lung volume reduction surgery.8–10
Therefore the aim of our study was to evaluate
the relationship between lung function parameters
and intensity of dyspnea as determinants of HRQL
in patients with pulmonary emphysema.Patients and methods
Patients
Forty (mean aged 6679) consecutive male patients
with pulmonary emphysema based on clinical and
radiological compatible pattern plus a diagnosis of
COPD with decrease in diffusion capacity for carbon
monoxide (TLCO)11 comprised the study popula-
tion. All patients fulfilled the following criteria: (1)
diagnosis of COPD according to the Global Initiative
for Chronic Obstructive Lung Disease criteria,22 (2)
TLCO o75% of the predicted, (3) stable clinical
respiratory condition within the last six weeks, (4)
absence of other major illness. Verbal informed
consent was obtained from all patients.
Methods
Lung function parameters, exercise performance,
clinical degree of dyspnea and HRQL were assessed
in all patients.
Lung function parameters
The following spirometric parameters were re-
corded: vital capacity (VC), forced vital capacity
(FVC), forced expiratory volume in one second
(FEV1) and FEV1/FVC. TLCO was measured using
single-breath technique and corrected for alveolar
volume (KCO). Spirometric and diffusion manoeu-
vers were performed according to the European
Respiratory Society Guidelines12,13 by mean of an
automatic equipment (Sensor Medics System 2100,
SensorMedics Corporation, California, 1984). The
following lung volumes were measured: total lung
capacity (TLC), residual volume (RV), RV/TLC,
functional residual capacity (FRC) and inspiratory
capacity (IC). Lung volumes were measured by bodyplethysmography (SensorMedics system 2800 trans-
mural body box. SensorMedics Corporation, Cali-
fornia, 1984). Maximum static inspiratory (MIP) and
expiratory (MEP) mouth pressures were measured
as described by Black and Hyatt,14 using a pressure
manometer Micro MPM (Sensor Medics). Measure-
ments of the maximal static respiratory pressures
were made while the subject was seated and wore
a noseclip. The patient held the manometer in his
hand and pressed the mouthpiece tightly against his
lips during the pressure measurement to prevent
perioral leak. MEP was measured near TLC after a
maximal inspiration. MIP was measured near RV
after a maximal expiration. The pressures mea-
sured were maintained for at least 1 s. The best
value of three measurements was reported. For the
purpose of this study MIP is expressed as a positive
value. European Community for Coal and Steel15 for
spirometry, TLCO and lung volumes, and Morales et
al.16 for maximum static pressure in a Mediterra-
nean population were used as reference predicted
values. Arterial blood samples were drawn from the
radial artery with the patient in sitting position
while breathing room air. Arterial blood gas analysis
was performed with an ABL-520 (Radiometer
Copenhagen).Exercise performance
Exercise performance was determinated as the best
value of two 6min walking test distance (6MWD)
performed on consecutive days,17 which was
performed in a hospital corridor 75m long. Patients
were asked to walk as far as possible in 6min. No
encouragement during the test was given.Health-related quality of life and dyspnea
The validated Spanish translation of the CRQD18
was employed for assessing HRQL. Twenty items
divided into four dimensions comprised CRQD
questionnaire: dyspnea (5 items), fatigue (4 items),
emotional function (7 items), and mastery (4
items). The lower and upper score for each
category were: 5–35, 4–28, 7–49 and 4–28, respec-
tively, with higher numbers representing better
function. Dyspnea was determinated using the
Baseline Dyspnea Index (BDI) and a modified
Medical Research Council (MCR) scale. BDI19 con-
sisted of five degrees for the categories: functional
impairment, magnitude of task and magnitude of
effort, with higher numbers representing better
function. The modified MCR scale20 included five
degrees of a variety of physical activities that
provoke dyspnea, with higher numbers represent-
ing worse function.
ARTICLE IN PRESS
Table 1 Baseline characteristics of the patients
studied (n=40).
Mean SD
Age (years) 66 9
BMI 23.4 4.0
FVC (%) 80.8 20.1
FEV1 (%) 42.0 16.1
FEV1/FVC 40.6 10.1
IC (L) 1.94 0.44
TLC (%) 113.9 19.9
RV (%) 159.5 51.6
RV/TLC (%) 53.7 10.5
TLCO (%) 41.57 15.47
KCO (%) 44.8 15
6MWD 349.7 101.1
MIP (cm H2O) 56.9 21.8
MIP (%) 55.1 20.2
MEP (cm H2O) 92.1 30.0
MEP (%) 52.0 16.2
PH 7.41 0.01
PO2 (mm Hg) 71.6 8.0
MCR 3.0 1.3
BDI 7.2 3.0
Magnitude of task 2.4 0.9
Functional impairment 2.4 1.1
Magnitude of effort 2.4 0.9
CRQD 97.9 21.4
Dyspnea 19.5 6.4
Fatigue 18.8 6.0
E. Gonza´lez et al.640Statistical analysis
Statistical analysis was performed using SPSS
(version 10.0) statistical software (SPSS Inc. Chica-
go, Illinois, USA). All data are expressed as mean
(SD) or frequency (percentage). Linear correlation
between variables was assessed using Pearson’s
linear correlation coefficient. P valueso0.05 were
considered statistically significant. The variables
that were significantly correlated with CRQD were
included in a principal-components factor analysis.
This technique was used to reduce or rearrange
large sets of variables to smaller sets of factors of
related variables or principal components.21 The
number of factors was determinated in order to an
optimal representation for each variable (commun-
ality more than 0.75). Factors were then rotated
to generate a varimax solution. Correlations
between these factor scores with CRQD were
evaluated. Stepwise multiple regression analyses
were performed to identify the most predictive
variables of HRQL. Only variables that showed
higher factor loading in varimax solution and
included in factors that were significantly corre-
lated with CRQD were used as independent
variables in the regression analysis. Dependent
variables for this model were global CRQD and
dimensions of CRQD: dyspnea, fatigue, emotional
function and mastery.Ef 36.6 9.6
Mastery 22.9 5.3
SD: standard deviation; (%): percent of predicted value;
BMI: body mass index (kg/m2); FVC: forced vital capacity;
FEV1: forced respiratory volume in the first second; IC:
inspiratory capacity in liters; TLC: total lung capacity; RV:
residual volume; TLCO: diffusion capacity for carbon
monoxide; KCO: diffusion capacity corrected for alveolar
volume; 6MWD: six min walking test distance in meters;
MIP: maximal inspiratory pressure in cm H2O; MEP:
maximal espiratory pressure in cm H2O; BDI: baseline
dyspnea index; MCR: Medical Research Council scale;
CRQD: Chronic Respiratory Questionnaire Disease; Ef:
emotional function.Results
Forty male patients with pulmonary emphysema
were studied. Seven (17.5%) presented very severe,
24 (60%) severe, 7 (17.5%) moderate and 2 (5%) mild
airway obstruction according to GOLD criteria (22).
Lung function parameters, exercise performance,
HRQL and dyspnea scales are shown in Table 1. FVC,
FEV1, KCO, MIP, MEP and 6MWD had a significant
correlation with several dimensions of CRQD (Table
2). However air trapping (measured as RV and RV/
TLC) was not correlated with CRQD. Dyspnea scales
(MCR and BDI) were significantly associated with all
dimensions of CRQD (Table 3). The 6MWD was
correlated with KCO (r ¼ 0:61; Po0.000) and with
MCR and BDI dyspnea scales (r ¼ 20:38; P ¼ 0:015
and r ¼ 0:37; P ¼ 0:017 respectively). Only MIP, but
not MEP, was correlated with MCR and BDI
(r ¼ 0:35; P ¼ 0:025 and r ¼ 0:34; P ¼ 0:031;
respectively).
The principal-components factor analysis yielded
four factors that accounted for 86.2% of the total
variance of the data. The Varimax rotation yielded
four interpretable factors, and the factor loadings
obteined for each rotated factor are displayed inTable 4. The first factor appear to be related to
FEV1 and vital capacity. Variables with high loading
on this factor included FEV1(%) and FVC(%). The
second factor appeared to be dyspnea, with BDI
and MCR loaded predominantly on this factor. The
third factor appeared to be diffusion capacity and
exercise performance, with KCO(%) and 6MWD
loaded on this factor. The fourth factor appeared
to be maximum static respiratory pressure, with
MEP and MIP loaded on this factor. Factors 2 and 4
was correlated with global CRQD (Fig. 1) and all
dimensions of CRQD (except dyspnea dimension,
which was not correlated with factor 4) (Table 5).
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Table 2 Pearson correlation coefficients (95% confidence interval) between lung function variables and CRQD.
CRQD
Global Dyspnea Fatigue Ef Mastery
FVC (%) 0.33 0.41 0.21 0.18 0.28
(0.02, 0.58) (0.11, 0.63) (0.10, 0.48) (0.13, 0.46) (0.03, 0.54)
FEV1 (%) 0.22 0.38
 0.04 0.08 0.22
(0.09, 0.49) (0.07, 0.61) (0.27, 0.34) (0.23, 0.38) (0.09, 0.49)
RV (%) 0.15 0.16 0.12 0.18 0.04
(0.44, 0.16) (0.44, 0.15) (0.41, 0.19) (0.46, 0.13) (0.27, 0.34)
RV/TLC 0.19 0.08 0.22 0.22 0.02
(0.47, 0.12) (0.38, 0.23) (0.49, 0.09) (0.49, 0.09) (0.32, 0.29)
6MWD 0.35 0.17 0.32 0.33 0.25
(0.04, 0.59) (0.14, 0.45) (0.01, 0.57) (0.02, 0.58) (0.06, 0.52)
KCO (%) 0.36 0.30 0.23 0.31 0.26
(0.05, 0.60) (0.00, 0.55) (0.08, 0.50) (0.00, 0.56) (0.05, 0.52)
MIP 0.31 0.17 0.25 0.23 0.32
(0.00, 0.56) (0.14, 0.45) (0.06, 0.52) (0.08, 0.5) (0.01, 0.57)
MEP 0.41 0.20 0.28 0.40 0.36
(0.11, 0.63) (0.11, 0.48) (0.03, 0.54) (0.10, 0.63) (0.05, 0.60)
See Table 1 for more abbreviations.
Pp0:05:
Table 3 Pearson correlation coefficients (95% confidence interval) between dyspnea scales and CRQD.
MCR BDI
Magnitude of task Functional impairment Magnitude of effort Global
CRQD 0.66 0.65 0.74 0.70 0.74
(0.80, 0.43) (0.42, 0.79) (0.55,0.85) (0.49, 0.83) (0.55,0.85)
Dyspnea 0.66 0.55 0.66 0.63 0.63
(0.80, 0.43) (0.28, 0.73) (0.43, 0.80) (0.39, 0.78) (0.39, 0.78)
Fatigue 0.50 0.63 0.68 0.54 0.65
(0.70, 0.22) (0.39, 0.78) (0.46, 0.81) (0.27, 0.72) (0.42, 0.79)
Ef 0.48 0.51 0.59 0.56 0.58
(0.68, 0.19) (0.23, 0.70) (0.34, 0.76) (0.30, 0.74) (0.32, 0.75)
Mastery 0.43 0.34 0.42 0.43 0.42
(0.65, 0.13) (0.03, 0.58) (0.12, 0.64) (0.13, 0.65) (0.12, 0.64)
See Table 1 for more abbreviations.
Pp0:05:
HRQL in patients with pulmonary emphysema 641Factor 1 and 3 was not correlated with any
dimension of CRQD.
On multivariate regression analysis, BDI and MEP
explained the 64% of the total variance of CRQD(Table 6). BDI and MEP explained the 46%, 44% and
23% of the variance of fatigue, emotional function
and mastery dimensions, respectively. However
MEP was not a predictive variable for dyspnea
ARTICLE IN PRESS
Table 4 Varimax rotated factor loadings.
Variables Factor number
1 2 3 4
FVC (%) 0.83 0.34 0.16 0.11
FEV1 (%) 0.83 0.21 0.23 0.01
BDI 0.26 0.91 0.11 0.06
MCR 0.22 0.90 0.22 0.08
KCO (%) 0.11 0.18 0.92 0.07
6MWD 0.36 0.15 0.72 0.27
MEP 0.14 0.05 0.16 0.90
MIP 0.49 0.11 0.11 0.78
See Table 1 for abbreviations.
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Figure 1 Correlation between CRQD and Factor 2. The
second factor appeared to be dyspnea, with BDI and MCR
loaded predominantly on this factor. CRQD: Chronic
Respiratory Questionnaire Disease.
E. Gonza´lez et al.642dimension. We calculated the impact of dyspnea
(measured with BDI scale) and MEP on HRQL. For
example, a decrease in the BDI scale of 10%
increased the CRQD score by 5.5% (95% confidence
interval: 4–7%), and an increase in the MEP of 10 cm
H2O increased the CRQD score by 2% (95% con-
fidence interval : 0.8–3.1%).Discussion
The present is the first study to evaluate the
relation between the degree of dyspnea, respira-
tory function parameters, exercise performance
and quality of life measured by HRQL question-
naires in patients with emphysema and withoutindication for lung volume reduction surgery. Only
two factors related to dyspnea and static respira-
tory pressure were significantly correlated with
different categories of CRQD on factor analysis.
Multiple regression analysis demonstrated that the
degree of dyspnea and MEP were independent
predictors of HRQL in patients with emphysema.
Type 2 error in a regression analysis consists in not
to consider a variable with a regression coefficient
different to zero. In our study the determination
coefficient (R2) calculated in the maximum model
(which included all possible independent variables)
was similar to that obtained in the final reduced
model (which included BDI and MEP only): 0.63
versus 0.64, respectively. Also, when calculated the
type 2 error for the excluded variables from the
final model this was well under 5% for values that
could modify significantly the prediction of the
model. Thus, we consider the probability of type 2
error in our regression model must be very low.
Although, previous studies have demonstrated a
weak correlation between airway obstruction and
HRQL score in patients with COPD,4–7 we have
failed to demonstrate any significant correlation
between the first factor, which is related to airway
obstruction, and the different categories of CRQD
in our population of patients with emphysema.
6MWD and KCO, loaded predominantly on factor
three, measure similar aspects of emphysema and
not surprisingly, had a significant correlation
between them (r ¼ 0:61; Po0.000). This finding is
in accordance with a previous publication in
patients with COPD.23 Several studies have shown
a significant correlation between 6MWD and
HRQL.4,24 Our study confirmed this correlation,
however 6MWD was excluded as predictive variable
on stepwise multiple regression model.
Patients with COPD have peripheral and respira-
tory muscle weakness.25,26 This might lead to
increase dyspnea27 and HRQL impairment.28 In this
study, MIP and MEP included in factor 4, were
correlated with all categories of CRQD, except
dyspnea dimension. MIP, but not MEP, was related
to dyspnea scale. The relation between inspiratory
muscle strength and dyspnea scale has been
reported previously.27 In this study, MEP, but not
MIP, reached statistical significance on stepwise
regression analysis and explained 10% of the
variance of CRQD. MEP was significantly associated
with fatigue, emotional function and mastery
categories. These findings might illustrate the
importance of expiratory muscle in HRQL of
patients with emphysema. Mahler Harver 27 demo-
strated in a group of COPD patients, that degree of
dyspnea and physiological function were indepen-
dent variables underscoring the pathophysiology of
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Table 6 Results of a multiple regression analysis with the CRQD and the four dimensions as dependent variables.
Cumulative R2 Beta Beta P
95% confidence interval
Lower limit Upper limit
CRQD
BDI 0.54 5.13 3.74 6.52 o0.000
MEP 0.64 0.24 0.10 0.37 0.001
CRQD ‘‘dyspnea’’
BDI 0.38 1.34 0.80 1.89 o0.000
CRQD ‘‘fatigue’’
BDI 0.41 1.28 0.80 1.76 o0.000
MEP 0.46 0.05 0.002 0.09 0.041
CRQD ‘‘emotional functional’’
BDI 0.33 1.80 1.02 2.57 o0.000
MEP 0.44 0.11 0.03 0.19 0.006
CRQD ‘‘mastery’’
BDI 0.15 0.71 0.20 1.22 0.007
MEP 0.23 0.05 0.003 0.10 0.038
See Table 1 for abbreviations.
Table 5 Pearson correlation coefficients (95% confidence interval) between CRQD and factors scores.
Factor 1 Factor 2 Factor 3 Factor 4
Airflow limitation Dyspnea Capacity of effort Maximum static
respiratory pressure
CRQD 0.05 0.70 0.19 0.30
(0.26, 0.35) (0.49, 0.83) (0.12, 0.47) (0.00, 0.55)
Dyspnea 0.14 0.68 0.15 0.01
(0.17, 0.43) (0.46, 0.81) (0.16, 0.44) (0.30, 0.32)
Fatigue 0.004 0.57 0.09 0.29
(0.30, 0.31) (0.31, 0.74) (0.22, 0.39) (0.00, 0.55)
Ef 0.06 0.53 0.20 0.32
(0.36, 0.25) (0.26, 0.72) (0.11, 0.48) (0.01, 0.57)
Mastery 0.13 0.38 0.12 0.29
(0.18, 0.42) (0.07, 0.61) (0.19, 0.41) (0.00, 0.55)
See Table 1 for abbreviations.
Pp0.05.
HRQL in patients with pulmonary emphysema 643the disease. In addition, dyspnea has been reported
to be strongly related to CRQD in COPD patients.24
These results are in keeping with our findings in our
emphysema population. Using factor analysis, we
have found that dyspnea scales (factor 2) and
pulmonary function test (factor 1, 3, and 4) were
separate and independent entities. Factor 2
was correlated with all dimensions of CRQD
(r ¼ 0:38 0:68). On multivariate regression ana-
lysis BDI scale was the best predictor of CRQD, andexplained 54% of the variance. Tsukino et al. 29
studied the physiologic factors that determine the
HRQL in patients with COPD, and identified three
different defined factors: airflow limitation, TLCO,
lifetime cigarette consumption and age. However,
the contribution of these factors to HQRL was
limited. Ketelaars et al.4 in a similar study, found
that FEV1, 12min walking test, and ‘‘emotional
reaction’’ of the COPD coping questionnaire were
predictive variables of HRQL in patients with severe
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E. Gonza´lez et al.644COPD (R2 ¼ 0:20 0:31). None of them included
dyspnea as predictive variable for HRQL. Jones et
al.3 using multiple regression, demostrated that
dyspnea, cough, wheeze, anxiety and 6MWD ex-
plained 72% of the variance of HRQL in patients
with COPD. In our study the inclusion of BDI scale in
multiple regression improved the model and ex-
plained the 64% of the variance. This emphasises
the strong contribution of dyspnea to HRQL in
patients with emphysema.
In conclusion, quality of life measured by CRQD
in patients with emphysema is predominantly
determined by dyspnea, and in minor degree
by expiratory muscle strength. Our results under-
score the usefulness of dyspnea scales and MEP
in the evaluation of HRQL of patients with
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